Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Why we are not a bunch of happy investors is besides me.

<< Previous

Bullboard Posts

Next >>

Comment by enriquesuaveon Mar 31, 2022 1:34pm

225 Views

Post# 34563816

RE:RE:Why we are not a bunch of happy investors is besides me.

MIBC might be another indication making them own the Bladder Cancer market in its entirety as a possibility. IMO. Animal studies have shown a 100% Tumor destruction in MIBC as well with same procedure.

Eoganacht wrote: Well put cashascars. The prospects for Theralase investors has never been better.

And once Theralase gets approval for it's NMIBC treatment, there will be the possibility of eventual off-label use for other forms of cancer. And there is a whole world of innovative research waiting to be verified and implemented. X-ray activation of systemically administered rutherrin for gbm and nsclc, anti-virus vaccines, new ruthenium compounds with unprecedented efficacy and proven inducement of immunogenic cell death in melanoma to name a few. Theralase has the IP it just needs funding.

cashascars wrote:
While I understand being impatient for an update from the company, if they are still waiting for pertinent information to put in it why the glum faces. We are 2 cents off the 52 week high and really more like 2 cents off the 2 1/2 year high, and this should put all of us in a positive position with our investment. Those that bought higher years ago at higher prices and are still holding likely bought more to average down so even they would be in the money. If you missed your opportunity to average down, well what can I say you missed a huge opportunity, but hope is still not over for you as this will easily go beyond all time highs by many multiples if the science proves up.

I'm pretty sure any big sellers here are investors who do not know the story, likely they bought into the .30 cent PP a few years ago and they see 50% on their money not including the trade able warrants that they likely sold off early on after the financing of which I bought plenty of under .10 cents in the first few days of their trading.

Now I will comment on any one who thinks negative news is on the table and this is the reason for the delay. This would be against the law to hold back releasing such news and I can not see them doing that. So the news we are waiting for is more likely positive in nature but they know they can wait while more data comes in and as long as the Data is similar to Novembers update they can hold on to it as long as they want as there is no real change to the progress of the Phase 2 except more of the same positive data over longer periods of time.
In this case No News is good news so far. Negative would need to have been released or needs to be released in a timely manner so no one can profit by the information.

Long Strong and happy but yes anxious for the GOOD news to be released.

Cashascars